Location History:
- Los Angeles, CA (US) (2008)
- Seattle, WA (US) (2016 - 2024)
Company Filing History:
6 out of 2,104 
1 out of 832,890 Years Active: 2008-2025
Title: Jay Wesley Chaplin: Innovator in Antigen Targeting
Introduction
Jay Wesley Chaplin is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of antigen targeting, holding a total of 7 patents. His work focuses on innovative methods that have the potential to impact disease treatment and management.
Latest Patents
Among his latest patents is a groundbreaking invention titled "Compositions and methods for antigen targeting to CD180." This invention provides compositions of CD180 targeting molecules coupled to heterologous antigens, and their use in treating and/or limiting disease. This patent reflects his commitment to advancing medical science through innovative solutions.
Career Highlights
Jay has had a distinguished career, working with esteemed institutions such as the University of Washington. His experience in research and development has allowed him to contribute significantly to the scientific community.
Collaborations
Throughout his career, Jay has collaborated with notable individuals, including Edward A Clark and Martha Susan Hayden-Ledbetter. These partnerships have enriched his work and expanded the impact of his inventions.
Conclusion
Jay Wesley Chaplin is a prominent figure in the field of antigen targeting, with a strong portfolio of patents that demonstrate his innovative spirit. His contributions continue to pave the way for advancements in medical treatments.